Total Payments
$294,282
2024 Payments
$58,188
Companies
20
Transactions
215
Medicare Patients
1,271
Medicare Billing
$169,950
Payment Breakdown by Category
Consulting$245,221 (83.3%)
Travel$23,205 (7.9%)
Other$16,968 (5.8%)
Research$4,752 (1.6%)
Food & Beverage$4,136 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $245,221 | 87 | 83.3% |
| Travel and Lodging | $23,205 | 56 | 7.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,758 | 3 | 3.0% |
| Unspecified | $4,752 | 4 | 1.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,585 | 1 | 1.6% |
| Food and Beverage | $4,136 | 63 | 1.4% |
| Honoraria | $3,625 | 1 | 1.2% |
Payments by Type
General
$289,530
211 transactions
Research
$4,752
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $69,384 | 37 | $0 (2024) |
| Kite Pharma, Inc. | $54,517 | 35 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $42,483 | 36 | $0 (2024) |
| Celgene Corporation | $30,205 | 28 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $16,596 | 13 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $12,778 | 15 | $0 (2017) |
| ADC Therapeutics America, Inc. | $10,329 | 7 | $0 (2024) |
| F. Hoffmann-La Roche AG | $9,229 | 3 | $0 (2017) |
| Ipsen Biopharmaceuticals, Inc | $7,395 | 6 | $0 (2021) |
| PFIZER INC. | $7,178 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $58,188 | 44 | Gilead Sciences, Inc. ($28,532) |
| 2023 | $15,859 | 21 | Gilead Sciences, Inc. ($4,750) |
| 2022 | $37,572 | 18 | Gilead Sciences, Inc. ($10,860) |
| 2021 | $39,888 | 22 | Celgene Corporation ($9,989) |
| 2020 | $37,687 | 22 | Kite Pharma, Inc. ($13,590) |
| 2019 | $53,400 | 34 | Kite Pharma, Inc. ($18,485) |
| 2018 | $25,704 | 30 | Kite Pharma, Inc. ($10,361) |
| 2017 | $25,984 | 24 | Bayer HealthCare Pharmaceuticals Inc. ($12,778) |
All Payment Transactions
215 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | EPKINLY (Drug) | Consulting Fee | Cash or cash equivalent | $725.00 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Genmab U.S., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,140.00 | General |
| 12/10/2024 | Janssen Research & Development, LLC | CARVYKTI (Drug), TECVAYLI | Consulting Fee | Cash or cash equivalent | $4,050.00 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Janssen Research & Development, LLC | CARVYKTI (Drug), TECVAYLI | Travel and Lodging | Cash or cash equivalent | $440.53 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Janssen Research & Development, LLC | CARVYKTI (Drug), TECVAYLI | Food and Beverage | In-kind items and services | $59.54 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Janssen Research & Development, LLC | CARVYKTI (Drug), TECVAYLI | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Oncology | ||||||
| 12/07/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $62.60 | General |
| 11/21/2024 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $19,630.00 | General |
| 11/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $288.11 | General |
| 11/14/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $237.27 | General |
| 11/11/2024 | Genentech USA, Inc. | Lunsumio (Biological), Columvi, Polivy | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| Category: BioOncology | ||||||
| 11/08/2024 | Genmab U.S., Inc. | — | Food and Beverage | Cash or cash equivalent | $55.20 | General |
| 11/08/2024 | Genmab U.S., Inc. | — | Food and Beverage | Cash or cash equivalent | $41.65 | General |
| 11/08/2024 | Genmab U.S., Inc. | — | Travel and Lodging | Cash or cash equivalent | $41.00 | General |
| 11/08/2024 | Genmab U.S., Inc. | — | Food and Beverage | Cash or cash equivalent | $31.52 | General |
| 11/08/2024 | Genmab U.S., Inc. | — | Food and Beverage | Cash or cash equivalent | $28.19 | General |
| 11/08/2024 | Genmab U.S., Inc. | — | Food and Beverage | Cash or cash equivalent | $28.19 | General |
| 11/03/2024 | Gilead Sciences, Inc. | Yescarta (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,370.00 | General |
| Category: CELLT | ||||||
| 11/03/2024 | Gilead Sciences, Inc. | Yescarta (Drug) | Travel and Lodging | In-kind items and services | $806.57 | General |
| Category: CELLT | ||||||
| 11/03/2024 | Gilead Sciences, Inc. | Yescarta (Drug) | Travel and Lodging | In-kind items and services | $729.92 | General |
| Category: CELLT | ||||||
| 11/03/2024 | Gilead Sciences, Inc. | Yescarta (Drug) | Travel and Lodging | In-kind items and services | $541.46 | General |
| Category: CELLT | ||||||
| 11/03/2024 | Gilead Sciences, Inc. | Yescarta (Drug) | Travel and Lodging | In-kind items and services | $482.14 | General |
| Category: CELLT | ||||||
| 11/03/2024 | Gilead Sciences, Inc. | Yescarta (Drug) | Travel and Lodging | In-kind items and services | $286.33 | General |
| Category: CELLT | ||||||
| 11/03/2024 | Gilead Sciences, Inc. | Yescarta (Drug) | Travel and Lodging | In-kind items and services | $152.08 | General |
| Category: CELLT | ||||||
| 11/01/2024 | Gilead Sciences, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $3.01 | General |
| Category: CELLT | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CTL019B2401 | Novartis Pharmaceuticals Corporation | $1,391 | 1 |
| PUBLICATION SUPPORT PROVIDED IN CONNECTION WITH HEOR RESEARCH | NOVARTIS PHARMACEUTICALS CORPORATION | $336.00 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 256 | 408 | $175,882 | $32,453 |
| 2022 | 8 | 330 | 558 | $232,713 | $45,065 |
| 2021 | 8 | 384 | 662 | $256,614 | $57,633 |
| 2020 | 8 | 301 | 470 | $150,181 | $34,800 |
Total Patients
1,271
Total Services
2,098
Medicare Billing
$169,950
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 51 | 88 | $64,196 | $10,654 | 16.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 102 | $28,356 | $6,889 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 101 | 127 | $35,249 | $5,862 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 45 | 55 | $22,465 | $4,209 | 18.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 23 | 23 | $20,351 | $3,557 | 17.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 12 | 13 | $5,265 | $1,281 | 24.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 47 | 86 | $61,286 | $10,391 | 17.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 29 | 97 | $38,703 | $8,462 | 21.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 32 | 109 | $30,302 | $6,611 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 65 | 78 | $31,182 | $6,046 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 95 | 122 | $33,030 | $6,041 | 18.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 27 | 27 | $23,341 | $4,204 | 18.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 17 | $8,687 | $1,950 | 22.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 21 | 22 | $6,182 | $1,360 | 22.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 38 | 150 | $59,850 | $13,448 | 22.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 53 | 95 | $57,179 | $11,925 | 20.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 84 | 121 | $40,839 | $9,818 | 24.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 50 | 50 | $35,538 | $7,862 | 22.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 81 | 108 | $24,840 | $5,504 | 22.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 27 | 84 | $23,352 | $5,239 | 22.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 31 | 33 | $8,991 | $2,508 | 27.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 20 | 21 | $6,025 | $1,329 | 22.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 22 | 79 | $29,805 | $7,301 | 24.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 43 | 43 | $25,116 | $6,413 | 25.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 37 | 66 | $31,968 | $6,075 | 19.0% |
About Dr. Caron Jacobson, MD
Dr. Caron Jacobson, MD is a Hematology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1336261379.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Caron Jacobson, MD has received a total of $294,282 in payments from pharmaceutical and medical device companies, with $58,188 received in 2024. These payments were reported across 215 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($245,221).
As a Medicare-enrolled provider, Jacobson has provided services to 1,271 Medicare beneficiaries, totaling 2,098 services with total Medicare billing of $169,950. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Hematology & Oncology, Medical Oncology
- Location Boston, MA
- Active Since 04/03/2007
- Last Updated 06/07/2011
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1336261379
Products in Payments
- Yescarta (Drug) $36,470
- KYMRIAH (Biological) $32,579
- Non-Covered $12,778
- Non-Covered Product (Drug) $9,229
- Tecartus (Drug) $8,424
- JCAR017 (Drug) $8,400
- KYMRIAH (Drug) $5,266
- CARVYKTI (Drug) $4,563
- TAZVERIK (Drug) $3,625
- MONJUVI (Drug) $2,768
- CALQUENCE (Drug) $2,740
- Lunsumio (Biological) $2,280
- BB-2121 (Drug) $2,025
- Revlimid (Drug) $1,595
- EPKINLY (Drug) $833.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Boston
Jacalyn Rosenblatt, M.d, M.D
Hematology — Payments: $1.6M
Hematology $1.6M
Jorge Castillo, Md, MD
Hematology — Payments: $922,724
Hematology $922,724
Dr. Edward Benz, Md, MD
Hematology — Payments: $746,999
Hematology $746,999
Andrew Evens, Do, Ms, DO, MS
Hematology — Payments: $339,696
Hematology $339,696
Lynn Bry, Md, MD
Hematology — Payments: $285,993
Hematology $285,993
Kenneth Miller, M.d, M.D
Hematology — Payments: $222,747
Hematology $222,747